Zhejiang Jolly Pharmaceutical Co.,Ltd.’s Net Profit Rose 113.6% in First Three Quarters of 2021

Zhejiang Jolly Pharmaceutical Co.,Ltd. (浙江佐力药业股份有限公司) (300181.SZ) reported a net profit of 141 million yuan in the first three quarters of 2021, up 113.6% year-on-year.

Meanwhile, the company posted 1.1 billion yuan in revenue, up 40.1% year-on-year.

At the end of the reporting period, it had 3.3 billion yuan in total assets and 899 million yuan in total liabilities, with a liability-to-asset ratio of 27.1%.

This article was automatically produced by Caixin Automation on Nov. 3, 2021.

Download our app to receive breaking news alerts and read the news on the go.

Follow the Chinese markets in real time with Caixin Global’s new stock database.